AU2003233947A1 - Method and agent for producing therapeutically active blood compositions - Google Patents

Method and agent for producing therapeutically active blood compositions

Info

Publication number
AU2003233947A1
AU2003233947A1 AU2003233947A AU2003233947A AU2003233947A1 AU 2003233947 A1 AU2003233947 A1 AU 2003233947A1 AU 2003233947 A AU2003233947 A AU 2003233947A AU 2003233947 A AU2003233947 A AU 2003233947A AU 2003233947 A1 AU2003233947 A1 AU 2003233947A1
Authority
AU
Australia
Prior art keywords
agent
therapeutically active
active blood
blood compositions
producing therapeutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003233947A
Other languages
English (en)
Inventor
Hans Meijer
Julio Reinecke
Peter Wehling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orthogen AG
Original Assignee
Orthogen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthogen AG filed Critical Orthogen AG
Publication of AU2003233947A1 publication Critical patent/AU2003233947A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Manufacturing & Machinery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
AU2003233947A 2002-03-22 2003-03-21 Method and agent for producing therapeutically active blood compositions Abandoned AU2003233947A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10213780.3 2002-03-22
DE10213780A DE10213780A1 (de) 2002-03-22 2002-03-22 Verfahren und Mittel zur Herstellung therapeutisch interessanter Blutzusammensetzungen
PCT/EP2003/002969 WO2003080122A1 (fr) 2002-03-22 2003-03-21 Procede et agent de fabrication de compositions sanguines therapeutiquement actives

Publications (1)

Publication Number Publication Date
AU2003233947A1 true AU2003233947A1 (en) 2003-10-08

Family

ID=28050919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003233947A Abandoned AU2003233947A1 (en) 2002-03-22 2003-03-21 Method and agent for producing therapeutically active blood compositions

Country Status (5)

Country Link
EP (1) EP1490112A1 (fr)
JP (1) JP2005529857A (fr)
AU (1) AU2003233947A1 (fr)
DE (1) DE10213780A1 (fr)
WO (1) WO2003080122A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010237191A1 (en) 2009-04-07 2011-11-03 Velin-Pharma A/S Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
JP5902088B2 (ja) * 2009-09-10 2016-04-13 フレミング・ヴェリンＦｌｅｍｍｉｎｇ ＶＥＬＩＮ マイクロｒｎａの製造方法およびその治療的応用
DE202009017772U1 (de) 2009-12-10 2011-04-21 Orthogen Ag Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
WO2012076194A1 (fr) 2010-12-10 2012-06-14 Orthogen Ag Préparations combinées contenant un antagoniste de la cytokine et un corticostéroïde
WO2012076193A1 (fr) 2010-12-10 2012-06-14 Orthogen Ag Préparations combinées contenant des exosomes et un corticostéroïde

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US20020034495A1 (en) * 1989-06-14 2002-03-21 W. French Anderson Gene therapy
WO2001075131A2 (fr) * 2000-03-31 2001-10-11 University Technology Corporation Compositions et procedes permettant de reguler le metabolisme de vegetaux

Also Published As

Publication number Publication date
EP1490112A1 (fr) 2004-12-29
JP2005529857A (ja) 2005-10-06
WO2003080122A1 (fr) 2003-10-02
DE10213780A1 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
AUPR638101A0 (en) Composition and method for treatment of disease
AU2003235403A1 (en) Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide
AU2003256253A1 (en) Aerosol for medical treatment and methods
AU2002226668A1 (en) Methods, systems and devices for in vivo electrochemical production of therapeutic agents
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
AU2009248461A1 (en) Ophthalmologic irrigation solutions and method
AU2003287443A1 (en) Compositions and methods for pain reduction
AU2003227229A1 (en) Method and device for manufacturing tissue section
AU2003232044A1 (en) Composition and method for dermatological treatment
AU2003219747A1 (en) Composition and method for coating medical devices
AU2003298945A1 (en) Method of preparing biologically active formulations
AUPS160602A0 (en) Therapeutic method
AU2003278806A1 (en) Composition and method for moisturizing nasal tissue
AU2003260241A1 (en) Buguzhi agent and composition and methods of preparing and administering the same
AU2003261903A1 (en) Blood fluidity improving agent
AU2003275709A1 (en) Therapeutic agent for spinal canal stenosis
AU2003233947A1 (en) Method and agent for producing therapeutically active blood compositions
AU2002363800A1 (en) Therapeutic agent composition and method of use
AU2002334123A1 (en) Anaesthetic compositions and method for their administration
AU2003215264A1 (en) Compositions and methods for delivery of skin cosmeceuticals
AU2003263962A1 (en) Tissue compositions and methods for producing same
AU2003275433A1 (en) Compositions and methods for treating pain
WO2004051549A8 (fr) Procede de liberation d'un agent actif
AU2002241270A1 (en) Compositions for delivering biologically active drug and method of using the same
AU2003246840A1 (en) Anti-hiv composition, production method thereof and medicament

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase